Menu
Recruiting NCT07682935

Investigation of the Effects of Angling as Supportive Therapy in Schizophrenia Treatment on Serum Parameters, Anxiety, Depression, and Quality of Life

No phase Interventional Angling Supportive Therapeutic Schizophrenia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: recreational fishing (angling).
Who it may be relevant to
Registry conditions: Angling, Supportive Therapeutic, Schizophrenia. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Angling as a Supportive Therapy in the Treatment of Schizophrenia

Overview

This study aims to evaluate the effects of recreational fishing (angling) as a supportive therapeutic intervention in individuals diagnosed with schizophrenia. Schizophrenia is a chronic psychiatric disorder characterized by disturbances in thinking, perception, emotion, and behavior, often accompanied by negative symptoms such as social withdrawal, anhedonia, and cognitive impairment, which significantly reduce quality of life. Recreational activities, particularly those involving nature-based engagement, have been shown to support psychological well-being through stress reduction, improved attention, and enhanced mood regulation. Angling is considered a mindfulness-like recreational activity that promotes relaxation, concentration, and emotional regulation, potentially offering benefits for individuals with psychiatric conditions. In this randomized controlled study, participants with schizophrenia will engage in a structured recreational fishing program in addition to standard care. The effects of the intervention will be evaluated on biochemical serum parameters, anxiety and depression levels, and quality of life outcomes. The study also aims to assess the psychosocial well-being of participants and determine the feasibility of integrating angling as an adjunctive non-pharmacological intervention in schizophrenia care. The findings are expected to contribute to evidence-based complementary treatment approaches in psychiatric rehabilitation.

Interventions

  • Behavioral recreational fishing (angling)
    Fishing will be done.

Primary outcome measures

  • The Positive and Negative Syndrome Scale [Time frame: Baseline and immediately after the 8-week intervention.]
  • Quality of Life Scale for Schizophrenia Patients [Time frame: Baseline and immediately after the 8-week intervention.]
  • UCLA Loneliness Scale [Time frame: Baseline and immediately after the 8-week intervention.]
  • Serum Beta-Endorphin Concentration [Time frame: Baseline and immediately after the 8-week intervention.]
  • Serum Serotonin Concentration [Time frame: Baseline and immediately after the 8-week intervention.]
  • Serum Cortisol Concentration [Time frame: Baseline and immediately after the 8-week intervention.]

Eligibility criteria

Inclusion criteria

  • Adults aged 18 years and older
  • Able to communicate verbally
  • Diagnosed with schizophrenia
  • Able to provide written informed consent

Exclusion criteria

  • Presence of comorbid psychiatric disorders other than schizophrenia
  • Patients in the acute psychotic (attack) phase

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • Fırat university — Elâzığ

Identifiers

NCT: NCT07682935 · 2026/09-43

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗